Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Loratadine Oral Solution vs Claritin Peach Syrup
NCT02593747Phase 1Completed
- Sponsor
- Bayer
- Start
- Dec 2015
- Primary completion
- Jan 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of loratadine in allergic rhinitis (AR) and urticaria (2 arms), sponsored by Bayer. Primary endpoints: Area Under the Concentration Versus Time Curve From Zero to the Last Data Point Greater Than Lower Limit of Quantitation and Maximum Observed Concentration. Started Dec 2015; status: completed.
02
Drugs
loratadine
03
Conditions
allergic rhinitis (AR)urticaria
Beyond the preview
Go deeper on NCT02593747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02593747.